PM Narendra Modi takes Bharat Biotech s Covaxin, allaying fears over Covid-19 vaccine s efficacy msn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from msn.com Daily Mail and Mail on Sunday newspapers.
Share
Aligarh: Dr Khalaf Saba, Department of Radio Diagnosis, J N Medical College (JNMC), Aligarh Muslim University (AMU) has been appointed as the Vice President of Resident Doctors’ Association (RDA) on ad-hoc basis; while Dr Mohammad Adil and Dr Radhika Arora of the Department of Pathology have been given the posts of ad-hoc General Secretary and Joint Secretary respectively. Related Posts
NEW DELHI - Doctors and experts say the government needs to improve its communication on drug safety amid concerns over the speedy approvals of vaccines, as well as glitches in a government app which resulted in only 64 per cent of intended recipients on the first two days of the nation s vaccine roll-out getting their shots.
The CoWIN app is being used by the government to alert recipients when it is their turn to get a shot.
India, which started vaccinations last Saturday (Jan 16), has approved two vaccines for emergency use: Covishield, developed by AstraZeneca and Oxford University, and Covaxin, developed by local firm Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV).
Out of the six nations, Bhutan is the first country to get the vaccine from India. As a gift from India, the first consignment of 1.5 lakh doses of COVID-19 vaccine 'Covishield' was dispatched to Thimphu, Bhutan from Chhatrapati Shivaji Maharaj International Airport, Mumbai in the wee hours of Wednesday.
Read more about Concerns after adverse events may be a factor for low vax turnout: Experts on Business Standard. Technical problems encountered initially could be another factor, experts say